CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
1500 mg/d elemental calcium as calcium carbonate +1 moredietary
Likely dose
1500 mg/d elemental calcium as calcium carbonatefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01161407
NCT01161407N/ACompleted
CompareCT.gov

Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease

Indiana University·interventional·Posted Jul 13, 2010·Updated Jul 29, 2014

In Brief

A clinical study evaluating 1500 mg/d elemental calcium as calcium carbonate and Placebo for Chronic Kidney Disease. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to gain a better understanding of calcium absorption and metabolism in patients with Chronic Kidney Disease (CKD) using calcium balance and kinetic methods.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesUnited States
CollaboratorsGenzyme, a Sanofi Company, Purdue University

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 13, 2010
Enrollment StartJun 1, 2010
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.0 years ago

Interventions

1500 mg/d elemental calcium as calcium carbonatedietary

500 mg elemental calcium as calcium carbonate given 3 times per day with meals for a total of 1500 mg/d elemental calcium. Given for 21 days in conjunction with a controlled diet.

Placebodietary

Placebo for calcium carbonate in same capsule form. Given 3 times per day with meals for 21 days in conjunction with a controlled diet.